3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
36
Neoplasms, Plasma Cell
12
Prostatic Neoplasms
4
Neoplasms
3
Lymphoma, Mantle-Cell
3
Immunoglobulin Light-chain Amyloidosis
3
Central Nervous System Neoplasms
3
Waldenstrom Macroglobulinemia
2
Sarcoma
2
Recurrence
2
Rectal Neoplasms
2
Neuroblastoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Glioma
2
Glioblastoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Amyloidosis
2
Adenocarcinoma of Lung
2
Renal Insufficiency, Chronic
1
Renal Insufficiency
1
Polyneuropathies
1
Paraproteinemias
1
Neurotoxicity Syndromes
1
Motor Activity
1
Interventions
fludarabine phosphate
41
Peripheral Blood Stem Cell Transplantation
36
Cytarabine
32
Cyclophosphamide
31
Whole-Body Irradiation
30
Busulfan
30
Tacrolimus
28
Mycophenolic Acid
27
Methotrexate
18
Etoposide
18
Cyclosporine
18
Antilymphocyte Serum
16
Filgrastim
15
Melphalan
13
Granulocyte Colony-Stimulating Factor
11
Idarubicin
10
Flow Cytometry
9
Clofarabine
9
Daunorubicin
8
sargramostim
7
Radiotherapy
7
Mitoxantrone
7
Cord Blood Stem Cell Transplantation
7
Transplantation
6
Thiotepa
6
Sirolimus
6
merphos
5
fludarabine
5
aldesleukin
5
Vorinostat
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Congenital Abnormalities
×
Thalidomide
×
Clear all
No trials found.